Menu
GeneBe

rs751153777

Variant summary

Our verdict is Likely benign. Variant got -4 ACMG points: 1P and 5B. PP2BP4BS2

The NM_002471.4(MYH6):c.3612G>C(p.Glu1204Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000126 in 1,607,924 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.000079 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00013 ( 0 hom. )

Consequence

MYH6
NM_002471.4 missense

Scores

8
11

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:4

Conservation

PhyloP100: 1.14
Variant links:
Genes affected
MYH6 (HGNC:7576): (myosin heavy chain 6) Cardiac muscle myosin is a hexamer consisting of two heavy chain subunits, two light chain subunits, and two regulatory subunits. This gene encodes the alpha heavy chain subunit of cardiac myosin. The gene is located approximately 4kb downstream of the gene encoding the beta heavy chain subunit of cardiac myosin. Mutations in this gene cause familial hypertrophic cardiomyopathy and atrial septal defect 3. [provided by RefSeq, Feb 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -4 ACMG points.

PP2
Missense variant where missense usually causes diseases, MYH6
BP4
Computational evidence support a benign effect (MetaRNN=0.3073111).
BS2
High AC in GnomAd at 12 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
MYH6NM_002471.4 linkuse as main transcriptc.3612G>C p.Glu1204Asp missense_variant 26/39 ENST00000405093.9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
MYH6ENST00000405093.9 linkuse as main transcriptc.3612G>C p.Glu1204Asp missense_variant 26/395 NM_002471.4 P1

Frequencies

GnomAD3 genomes
AF:
0.0000791
AC:
12
AN:
151772
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000727
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000132
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000846
AC:
21
AN:
248168
Hom.:
0
AF XY:
0.0000744
AC XY:
10
AN XY:
134492
show subpopulations
Gnomad AFR exome
AF:
0.0000629
Gnomad AMR exome
AF:
0.0000870
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000153
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000131
AC:
191
AN:
1456152
Hom.:
0
Cov.:
34
AF XY:
0.000131
AC XY:
95
AN XY:
723798
show subpopulations
Gnomad4 AFR exome
AF:
0.0000300
Gnomad4 AMR exome
AF:
0.0000672
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000166
Gnomad4 OTH exome
AF:
0.0000499
GnomAD4 genome
AF:
0.0000791
AC:
12
AN:
151772
Hom.:
0
Cov.:
31
AF XY:
0.0000540
AC XY:
4
AN XY:
74104
show subpopulations
Gnomad4 AFR
AF:
0.0000727
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000132
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000130
Hom.:
0
Bravo
AF:
0.0000529
ExAC
AF:
0.0000577
AC:
7

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpMay 31, 2022Variant summary: MYH6 c.3612G>C (p.Glu1204Asp) results in a conservative amino acid change located in the Myosin tail of the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 8.5e-05 in 248168 control chromosomes. The observed variant frequency is approximately 3.38 fold of the estimated maximal expected allele frequency for a pathogenic variant in MYH6 causing Cardiomyopathy phenotype (2.5e-05), suggesting that the variant is benign. c.3612G>C has been reported in the literature in an individual who died suddenly of unexplained causes, without strong evidence for causality (Sanchez_2016). This report does not provide unequivocal conclusions about association of the variant with Cardiomyopathy. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as VUS. -
Hypertrophic cardiomyopathy 14 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingInvitaeJan 18, 2024This sequence change replaces glutamic acid, which is acidic and polar, with aspartic acid, which is acidic and polar, at codon 1204 of the MYH6 protein (p.Glu1204Asp). This variant is present in population databases (rs751153777, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with MYH6-related conditions. ClinVar contains an entry for this variant (Variation ID: 264374). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt MYH6 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Dilated cardiomyopathy 1EE;C2750467:Hypertrophic cardiomyopathy 14;C3279790:Atrial septal defect 3;C3279791:Sick sinus syndrome 3, susceptibility to;C3495498:Hypertrophic cardiomyopathy 1 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsSep 14, 2021- -
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsNov 23, 2023The p.E1204D variant (also known as c.3612G>C), located in coding exon 24 of the MYH6 gene, results from a G to C substitution at nucleotide position 3612. The glutamic acid at codon 1204 is replaced by aspartic acid, an amino acid with highly similar properties. This variant has been detected in an individual reported to have hypertrophic cardiomyopathy and in a sudden death case; however, details were limited and other variants in cardiac-related genes were also detected (Sanchez O et al. PLoS One, 2016 Dec;11:e0167358; van Lint FHM et al. Neth Heart J, 2019 Jun;27:304-309). This amino acid position is well conserved in available vertebrate species; however, aspartic acid is the reference amino acid in two species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this variant remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Benign
-0.36
Cadd
Benign
22
Dann
Uncertain
0.99
DEOGEN2
Uncertain
0.63
D;D
Eigen
Benign
-0.15
Eigen_PC
Benign
-0.096
FATHMM_MKL
Benign
0.69
D
LIST_S2
Uncertain
0.93
D;.
M_CAP
Uncertain
0.12
D
MetaRNN
Benign
0.31
T;T
MetaSVM
Uncertain
-0.17
T
MutationAssessor
Benign
1.2
L;L
MutationTaster
Benign
0.98
D;D
PrimateAI
Uncertain
0.77
T
PROVEAN
Benign
-2.1
N;N
REVEL
Uncertain
0.40
Sift
Benign
0.038
D;D
Sift4G
Uncertain
0.044
D;D
Polyphen
0.0020
B;B
Vest4
0.41
MutPred
0.66
Gain of catalytic residue at I1209 (P = 0.0055);Gain of catalytic residue at I1209 (P = 0.0055);
MVP
0.84
MPC
1.6
ClinPred
0.039
T
GERP RS
3.3
Varity_R
0.17
gMVP
0.24

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs751153777; hg19: chr14-23859386; API